Inhaled anxiety drug tested for abuse risk in sedative users
NCT ID NCT00603980
First seen May 05, 2026 · Last updated May 05, 2026
Summary
This study looked at whether an inhaled form of the anti-anxiety drug alprazolam is more or less likely to be abused than the standard pill form. Thirty-one adults with a history of sedative abuse took part. They rated how much they liked each drug and whether they would take it again. The goal was to understand the abuse potential of the inhaled version.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABUSE LIABILITY OF STACCATO ALPRAZOLAM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21224, United States
Conditions
Explore the condition pages connected to this study.